Structure elucidation of colibactin and its DNA cross-links

Strains of the human gut bacterium Escherichia coli carrying the clb gene cluster produce a secondary metabolite dubbed colibactin and have been provocatively linked to colorectal cancer in some models. Colibactin has been difficult to isolate in full, but pieces of the structure have been worked ou...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 365; no. 6457; p. 1000
Main Authors Xue, Mengzhao, Kim, Chung Sub, Healy, Alan R., Wernke, Kevin M., Wang, Zhixun, Frischling, Madeline C., Shine, Emilee E., Wang, Weiwei, Herzon, Seth B., Crawford, Jason M.
Format Journal Article
LanguageEnglish
Published United States American Association for the Advancement of Science 06.09.2019
The American Association for the Advancement of Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Strains of the human gut bacterium Escherichia coli carrying the clb gene cluster produce a secondary metabolite dubbed colibactin and have been provocatively linked to colorectal cancer in some models. Colibactin has been difficult to isolate in full, but pieces of the structure have been worked out, including an electrophilic warhead. Xue et al. found that colibactin contains two conjoined warheads, which is consistent with its ability to alkylate and cross-link DNA. Chemical synthesis and comparison to cell coculture confirm the structure and properties of this unstable and potentially carcinogenic metabolite. Science , this issue p. eaax2685 A DNA cross-linking metabolite from gut microbes is made by joining two precursor units. Colibactin is a complex secondary metabolite produced by some genotoxic gut Escherichia coli strains. The presence of colibactin-producing bacteria correlates with the frequency and severity of colorectal cancer in humans. However, because colibactin has not been isolated or structurally characterized, studying the physiological effects of colibactin-producing bacteria in the human gut has been difficult. We used a combination of genetics, isotope labeling, tandem mass spectrometry, and chemical synthesis to deduce the structure of colibactin. Our structural assignment accounts for all known biosynthetic and cell biology data and suggests roles for the final unaccounted enzymes in the colibactin gene cluster.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
M.X. discovered and characterized the natural colibactin-diadenine adduct 9, conducted tandem MS analysis of synthetic colibactin-DNA adducts, carried out bacterial infection studies, and identified the colibactin-adenine adducts 9, S1, 4, and 14 in genomic DNA; C.S.K. characterized natural colibactin (17) and precolibactin 1489 (18) in bacterial extracts; A.R.H. contributed to the conception of the synthesis, conducted preliminary synthetic studies, and suggested protection of the fragment coupling product 24 as its enoxysilane; K.M.W. conceived the twofold coupling approach to colibactin, developed a synthesis of the β-ketothioeseter 25, and optimized the synthetic route; Z.W. optimized the synthetic route and completed the synthesis of colibactin; M.C.F. developed a scalable synthetic route to the α-nitroketone 33; E.E.S. generated new strains, contributed to the bacterial infection studies, and developed the clbS mutant strategy to enhance detection of natural colibactin; and W.W. assisted with tandem MS analysis of DNA-colibactin adducts. S.B.H. and J.M.C. conceived the study, oversaw experiments, and wrote the manuscript.
Author contributions
Contributed equally
ISSN:0036-8075
1095-9203
1095-9203
DOI:10.1126/science.aax2685